The Prognostic Reliability of Inflammatory Biomarkers in Temporomandibular Joint Disorder - A Systematic Review.
Researchers reviewed evidence on whether inflammatory markers in temporomandibular joint fluid could predict treatment outcomes and disease progression in TMD patients, finding that elevated interleukin-1β, interleukin-6 and tumour necrosis factor-alpha showed consistent associations with disease severity, though study heterogeneity limited definitive conclusions.
A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.
Read the full study at the sourceThe Recall — the month's most significant new dental research, summarised. Free.
Browse The Recall